(3,4-dihydro-quinazolin-2-yl)-(2-aryloxyethyl)-amines having an activity on the 5-HT receptor

Details for Australian Patent Application No. 2006243244 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Peters, Jens-Uwe; Alanine, Alexander; Luebbers, Thomas; Steward, Lucinda; Kolczewski, Sabine; Gobbi, Luca Claudio

Agent Spruson & Ferguson

Pub. Number AU-A-2006243244

PCT Pub. Number WO2006/117305

Priority 05103744.8 04.05.05 EP

Filing date 24 April 2006

Wipo publication date 9 November 2006

International Classifications

C07D 239/84 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

15 November 2007 PCT application entered the National Phase

  PCT publication WO2006/117305 Priority application(s): WO2006/117305

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006243245-Heterocyclic antiviral compounds

2006243243-Tetracyclic azapyrazinoindolines as 5-HT2 ligands